TCHP and melanoma: Cyclin-dependent kinase inhibitor 2A (CDKN2A), encoding the two tumor-suppressor proteins p14<sup>ARF</sup> and p16<sup>INK4a</sup>, belongs to the most frequently inactivated gene loci in melanoma and leads to decreased T cell infiltration.